For T1-2N0 very low risk disease the TAILORx data demonstrated a less than 5% risk of distant recurrence regardless of clinical risk. (Sparano et al NEJM 2019) The majority of premenopausal were given tamoxifen alone. The absolute difference between tamoxifen and OFS/AI in such a low risk group woul...